Omega-3 fatty acid supplementation reduced interleukin-6 levels by an unspecified amount in aged rats exposed to propionic acid-induced neurotoxicity, but failed to normalize tumor necrosis factor-α or oxidative stress markers. The intervention showed incomplete restoration of tight-junction proteins, with only compensatory CLDN2 expression increases observed.
This finding challenges the prevailing optimism around omega-3s as therapeutic interventions for neuroinflammation and gut barrier dysfunction. The study's focus on aged animals is particularly relevant, as most omega-3 research examines younger subjects despite aging being when these interventions are most needed clinically. The modest anti-inflammatory effects suggest omega-3s may hit a therapeutic ceiling in established pathology, supporting a prevention-over-treatment paradigm. However, the study's limitations are significant: the small sample size of 24 rats divided into four groups provides limited statistical power, and the artificial propionic acid model may not accurately reflect natural gut-brain axis deterioration. The research reinforces emerging evidence that timing matters critically in nutritional interventions—what works preventively may prove inadequate therapeutically once inflammatory cascades are established.